HER2-targeted antibody drug conjugate shows strong anti-tumor activity and durable responses across multiple tumors

Posted on

HER2-targeted antibody drug conjugate shows strong anti-tumor activity and durable responses across multiple tumors
Source: Read Full Article

Related posts:
  1. Sepsis test being trialled for newborn babies could miss 30% of cases
  2. Nearly 500K Aetna members affected by EyeMed security incident
  3. Good Survival, Outcomes With TARE for HCC
  4. Innate and adaptive immune responses to BNT162b2 vaccination in mice
  5. Study proves that antivenom reduces risk of skin necrosis in patients bitten by brown recluse spider
Related posts